Literature DB >> 19342053

Hyperhomocysteinemia, intima-media thickness and C677T MTHFR gene polymorphism: a correlation study in patients with cognitive impairment.

Gaetano Gorgone1, Francesca Ursini, Claudia Altamura, Federica Bressi, Mario Tombini, Giuseppe Curcio, Paola Chiovenda, Rosanna Squitti, Mauro Silvestrini, Riccardo Ientile, Francesco Pisani, Paolo Maria Rossini, Fabrizio Vernieri.   

Abstract

OBJECTIVE: Intima-media thickness (IMT) seems associated with risk of Alzheimer disease (AD). Homocysteine (hcy) is a risk factor for vascular diseases and dementia. This study aimed at investigating the possible relationship among IMT, plasma hcy and C677T methylentetrahydrofolate reductase (MTHFR) polymorphism in relation to cognitive status.
METHODS: Sixty-three patients with cognitive impairment and 64 controls underwent biochemical, neuropsychological and carotid ultrasound assessment.
RESULTS: After age and folate adjustment, plasma hcy correlated with both Mini Mental State Examination (MMSE) score (r=-0.7, p<0.01) and IMT (r=0.7, p<0.01). Among patients with cognitive impairment, carriers of TT677 MTHFR genotype had plasma hcy (p<0.001) and IMT (p<0.01) values higher than non carriers. Furthermore, multiple regression analysis showed that MMSE scores were associated with plasma hcy (beta=-0.3, p=0.01), IMT (beta=-0.3, p=0.01) and TT677 MTHFR genotype (beta=-0.3, p=0.02). Structural equation modelling showed that the relation between hcy levels and MMSE score was partly direct (parameter estimate=-0.6; p=0.01) and partly mediated by IMT values (parameter estimate=-0.4; p=0.03). Finally, IMT resulted associated with hypertension (parameter estimate=0.8; p<0.0001).
CONCLUSION: Our findings suggest that TT677 MTHFR genotype promotes plasma homocysteine increase which in turn may favour intima-media thickening in patients with cognitive impairment. Hcy may promote neuronal damage through multiple mechanisms, including a micro-vascular damage, mediated by IMT increase, and a direct neuro-toxic effect.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19342053     DOI: 10.1016/j.atherosclerosis.2009.02.028

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  15 in total

1.  The 894G > T (Glu298Asp) variant in the endothelial NOS gene and MTHFR polymorphisms influence homocysteine levels in patients with cognitive decline.

Authors:  Nadia Ferlazzo; Gaetano Gorgone; Daniela Caccamo; Monica Currò; Salvatore Condello; Francesco Pisani; Fabrizio Vernieri; Paolo Maria Rossini; Riccardo Ientile
Journal:  Neuromolecular Med       Date:  2011-05-24       Impact factor: 3.843

2.  X-ray imaging of differential vascular density in MMP-9-/-, PAR-1-/+, hyperhomocysteinemic (CBS-/+) and diabetic (Ins2-/+) mice.

Authors:  S Givvimani; U Sen; N Tyagi; C Munjal; S C Tyagi
Journal:  Arch Physiol Biochem       Date:  2010-09-14       Impact factor: 4.076

3.  Transcranial doppler ultrasound blood flow velocity and pulsatility index as systemic indicators for Alzheimer's disease.

Authors:  Alex E Roher; Zsolt Garami; Suzanne L Tyas; Chera L Maarouf; Tyler A Kokjohn; Marek Belohlavek; Linda J Vedders; Donald Connor; Marwan N Sabbagh; Thomas G Beach; Mark R Emmerling
Journal:  Alzheimers Dement       Date:  2011-03-09       Impact factor: 21.566

4.  MMP-9 gene ablation mitigates hyperhomocystenemia-induced cognition and hearing dysfunction.

Authors:  Seema Bhargava; Sathnur Pushpakumar; Naira Metreveli; Srikanth Givvimani; Suresh C Tyagi
Journal:  Mol Biol Rep       Date:  2014-08       Impact factor: 2.316

5.  Genetic influence of plasma homocysteine on Alzheimer's disease.

Authors:  Tina Roostaei; Daniel Felsky; Arash Nazeri; Philip L De Jager; Julie A Schneider; David A Bennett; Aristotle N Voineskos
Journal:  Neurobiol Aging       Date:  2017-10-13       Impact factor: 4.673

6.  Nitric oxide as an initiator of brain lesions during the development of Alzheimer disease.

Authors:  Gjumrakch Aliev; Hector H Palacios; Amanda E Lipsitt; Kathryn Fischbach; Bruce T Lamb; Mark E Obrenovich; Ludis Morales; Eldar Gasimov; Valentin Bragin
Journal:  Neurotox Res       Date:  2009-05-30       Impact factor: 3.911

Review 7.  Pathology supported genetic testing and treatment of cardiovascular disease in middle age for prevention of Alzheimer's disease.

Authors:  Maritha J Kotze; Susan J van Rensburg
Journal:  Metab Brain Dis       Date:  2012-04-19       Impact factor: 3.584

8.  Correlation of homocysteine metabolic enzymes gene polymorphism and mild cognitive impairment in the Xinjiang Uygur population.

Authors:  Mei Luo; Huihui Ji; Xiaohui Zhou; Jie Liang; Ting Zou
Journal:  Med Sci Monit       Date:  2015-01-27

Review 9.  Impaired Aβ clearance: a potential link between atherosclerosis and Alzheimer's disease.

Authors:  Ajay Gupta; Costantino Iadecola
Journal:  Front Aging Neurosci       Date:  2015-06-16       Impact factor: 5.750

10.  Association of MTHFR, SLC19A1 Genetic Polymorphism, Serum Folate, Vitamin B12 and Hcy Status with Cognitive Functions in Chinese Adults.

Authors:  Can Cai; Rong Xiao; Nicholas Van Halm-Lutterodt; Jie Zhen; Xiaochen Huang; Yao Xu; Shuying Chen; Linhong Yuan
Journal:  Nutrients       Date:  2016-10-24       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.